Concomitant endothelin-1 overexpression in lung transplant donors and recipients predicts primary graft dysfunction

American Journal of Transplantation

Volumn 10, Issue 3, 2010, Pages 628-636

  Salama, M ^a   Andrukhova, O ^a   Hoda, M A ^a   Taghavi, S ^a   Jaksch, P ^a   Heinze, G ^a   Klepetko, W ^a   Aharinejad, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelin 1; Lung transplantation; Marker; Primary graft dysfunction

Indexed keywords

ENDOTHELIN 1; MESSENGER RNA;

ADULT; ARTICLE; BLOOD OXYGENATION; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG EDEMA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PREOPERATIVE PERIOD; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DONORS; TREATMENT OUTCOME;

EID: 76949085987     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02957.x     Document Type: Article

References (37)

1. Orens JB, Garrity ER Jr. General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc 2009 6 : 13 19.
2. Ailawadi G, Lau CL, Smith PW et al. Does reperfusion injury still cause significant mortality after lung transplantation? J Thorac Cardiovasc Surg 2009 137 : 688 694.
3. Carter YM, Davis RD. Primary graft dysfunction in lung transplantation. Semin Respir Crit Care Med 2006 27 : 501 507.
4. Huang HJ, Yusen RD, Meyers BF et al. Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant 2008 8 : 2454 2462.
5. Christie JD, Van Raemdonck D, de Perrot M et al. Report of the ISHLT Working Group on primary lung graft dysfunction. Part I: Introduction and methods. J Heart Lung Transplant 2005 24 : 1451 1453. (Pubitemid 41396438)
6. Barr ML, Kawut SM, Whelan TP et al. Report of the ISHLT Working Group on primary lung graft dysfunction. Part IV: Recipient-related risk factors and markers. J Heart Lung Transplant 2005 24 : 1468 1482.
7. De Perrot M, Bonser RS, Dark J et al. Report of the ISHLT Working Group on primary lung graft dysfunction. Part III: Donor-related risk factors and markers. J Heart Lung Transplant 2005 24 : 1460 1467. (Pubitemid 41396440)
8. Christie JD, Bavaria JE, Palevsky HI et al. Primary graft failure following lung transplantation. Chest 1998 114 : 51 60.
9. Lee JC, Christie JD. Primary graft dysfunction. Proc Am Thorac Soc 2009 6 : 39 46.
10. Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: The role of brain death in donor lung injury. Transplantation 2003 75 : 1928 1933.
11. Avlonitis VS, Wigfield CH, Golledge HD, Kirby JA, Dark JH. Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant 2007 7 : 83 90.
12. Fagan KA, McMurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res 2001 2 : 90 101.
13. Jeppsson A, Tazelaar HD, Miller VM, McGregor CG. Distribution of endothelin-1 in transplanted human lungs. Transplantation 1998 66 : 806 809.
14. Shennib H, Serrick C, Saleh D, Adoumie R, Stewart DJ, Giaid A. Alterations in bronchoalveolar lavage and plasma endothelin-1 levels early after lung transplantation. Transplantation 1995 59 : 994 998.
15. Tikkanen JM, Koskinen PK, Lemström KB. Role of endogenous endothelin-1 in transplant obliterative airway disease in the rat. Am J Transplant 2004 4 : 713 720.
16. Uguccioni M, Pulsatelli L, Grigolo B et al. Endothelin-1 in idiopathic pulmonary fibrosis. J Clin Pathol 1995 48 : 330 334.
17. Taghavi S, Abraham D, Riml P et al. Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. J Heart Lung Transplant 2002 21 : 600 603.
18. Shennib H, Lee AG, Kuang JQ, Yanagisawa M, Ohlstein EH, Giaid A. Efficacy of administering an endothelin-receptor antagonist (SB209670) in ameliorating ischemia-reperfusion injury in lung allografts. Am J Respir Crit Care Med 1998 157 : 1975 1981.
19. Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, Aharinejad S. Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant 2007 7 : 700 706.
20. Shargall Y, Guenther G, Ahya VN, Ardehali A, Singhal A, Keshavjee S. Report of the ISHLT Working Group on primary lung graft dysfunction. Part VI: Treatment. J Heart Lung Transplant 2005 24 : 1489 1500. (Pubitemid 41396443)
21. Aharinejad S, Krenn K, Paulus P et al. Differential role of TGF-beta1/bFGF and ET-1 in graft fibrosis in heart failure patients. Am J Transplant 2005 5 : 2185 2192.
22. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Statistics in Medicine 2002 21 : 2409 2419.
23. Carter YM, Gelman AE, Kreisel D. Pathogenesis, management, and consequences of primary graft dysfunction. Semin Thorac Cardiovasc Surg 2008 20 : 165 172.
24. Naidu BV, Woolley SM, Farivar AS et al. Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2004 127 : 1502 1508.
25. Hoffman SA, Wang L, Shah CV et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 2009 9 : 389 396.
26. Iwata T, Philipovskiy A, Fisher AJ et al. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 2008 181 : 5738 5747.
27. Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Szmitkowski M, Mroczko B. The role of endothelium-derived mediators in exercise-induced bronchoconstriction. Int Arch Allergy Immunol 2007 143 : 299 310.
28. Comellas AP, Briva A, Dada LA et al. Endothelin-1 impairs alveolar epithelial function via endothelial ETB receptor. Am J Respir Crit Care Med 2009 179 : 113 122.
29. Skovgaard N, Zibrandtsen H, Laursen BE, Simonsen U, Wang T. Hypoxia-induced vasoconstriction in alligator (Alligator mississippiensis) intrapulmonary arteries: A role for endothelin-1? J Exp Biol 2008 211 : 1565 1570.
30. Sutherland AJ, Ware RS, Winterford C, Fraser JF. The endothelin axis and gelatinase activity in alveolar macrophages after brain-stem death injury: A pilot study. J Heart Lung Transplant 2007 26 : 1040 1047.
31. Oto T, Excell L, Griffiths AP et al. Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor. Am J Transplant 2008 8 : 2132 2139.
32. Giaid A, Yanagisawa M, Langleben D et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993 328 : 1732 1739. (Pubitemid 23170122)
33. Trow TK, Taichman DB. Endothelin receptor blockade in the management of pulmonary arterial hypertension: Selective and dual antagonism. Respir Med 2009 Mar 20 [Epub ahead of print].
34. Barklin A. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 2009 53 : 425 435.
35. Nyhof E, Wiehl S, Steinhoff J, Krüger S, Mueller-Steinhardt M, Fricke L. Relationship between donor factors, immunogenic up-regulation, and outcome after kidney transplantation. Transplant Proc 2005 37 : 1605 1607.
36. Jager KJ, Zoccali C, Macleod A, Dekker FW. Confounding: What it is and how to deal with it. Kidney Int 2008 73 : 256 260.
37. Wort SJ, Mitchell JA, Woods M, Evans TW, Warner TD. The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells. J Cardiovasc Pharmacol 2000 36 : 410 413.